Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Top Buys From The Best Money Managers (Q2 2022)
11:30am, Wednesday, 17'th Aug 2022 Seeking Alpha
I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. See the top buys from best money managers during Q2.
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
05:54pm, Friday, 29'th Jul 2022 Zacks Investment Research
Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
03:33pm, Friday, 29'th Jul 2022
Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
02:31pm, Friday, 29'th Jul 2022 Benzinga
Upgrades
For The Carlyle Group Inc (NASDAQ:CG), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. Carlyle Group earned $1.17 in the second quarter, compared to $0.88 in the ye
Roku, Intel And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
12:13pm, Friday, 29'th Jul 2022 Benzinga
Roku, Inc. (NASDAQ: ROKU) shares fell 24.3% to $64.45 in pre-market trading after the company reported weaker-than-expected financial results for its second quarter and withdrew its full-year revenue
Edwards Lifesciences (EW) Q2 2022 Earnings Call Transcript
10:30am, Friday, 29'th Jul 2022 The Motley Fool
EW earnings call for the period ending June 30, 2022.
Edwards Lifesciences (EW) Matches Q2 Earnings Estimates
09:45pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 1.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook
08:54pm, Thursday, 28'th Jul 2022 Benzinga
Edwards Lifesciences Corp (NYSE: EW) reported second-quarter sales of $1.37 billion, flat compared to 2Q21, missing the consensus of $1.4 billion.
Adjusted EPS was $0.63, which missed the consensus
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2022 Results - Earnings Call Transcript
08:00pm, Thursday, 28'th Jul 2022
Edwards Lifesciences Corporation (NYSE:EW ) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET Company Participants Mark Wilterding - VP, IR and Treasurer Mike Mussallem - Chairman and CEO Scot
Edwards Lifesciences (EW) Matches Q2 Earnings Estimates
07:30pm, Thursday, 28'th Jul 2022
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 1.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences (EW) to Post Q2 Earnings: What's in Store?
04:18pm, Monday, 25'th Jul 2022 Zacks Investment Research
Edwards Lifesciences' (EW) Q2 performance will likely reflect the continued adoption of the RESILIA tissue valves and enhanced sales of the HemoSphere platform.
Edwards Lifesciences (EW) to Post Q2 Earnings: What's in Store?
01:56pm, Monday, 25'th Jul 2022
Edwards Lifesciences' (EW) Q2 performance will likely reflect the continued adoption of the RESILIA tissue valves and enhanced sales of the HemoSphere platform.
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 28, 2022
07:05am, Thursday, 21'st Jul 2022
IRVINE, Calif. , July 21, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2022 after the market closes on Thursday, July 28,
A Debt-Free and Fairly Valued Medical Devices Company
02:42pm, Wednesday, 20'th Jul 2022
LeMaitre Vascular Inc. ( LMAT , Financial) has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.
4 Profitable Companies With Solid Financial Conditions
11:23am, Wednesday, 20'th Jul 2022
When screening the market for value opportunities, investors may want to consider stocks that represent companies with high profitability and robust financial conditions. The companies below meet thes
